Ozanezumab Biosimilar – Anti-RTN4, NOGO mAb – Research Grade

Reference:
Product nameOzanezumab Biosimilar - Anti-RTN4, NOGO mAb - Research Grade
SourceCAS 1310680-64-8
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsOzanezumab,GSK-1223249,RTN4, NOGO,anti-RTN4, NOGO
ReferencePX-TA1313
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-nd
ClonalityMonoclonal Antibody

Description of Ozanezumab Biosimilar - Anti-RTN4/NOGO mAb - Research Grade

General information on Anti-RTN4/NOGO[Homo sapiens] (Ozanezumab) Monoclonal Antibody

Ozanezumab has been investigated for the treatment of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis, Relapsing-Remitting.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Ozanezumab Biosimilar – Anti-RTN4, NOGO mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 189$
Stable Isotope Labelled Ozanezumab Biosimilar – Anti-RTN4/NOGO mAb – Research Grade
SIL

Stable Isotope Labelled Ozanezumab Biosimilar – Anti-RTN4/NOGO mAb – Research Grade

PX-TA1313-SIL 15750$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products